FREE Account Opening + No Clearing Fees
Loading...

Paytm IPO vs Windlas Biotech IPO

Comparision between Paytm IPO and Windlas Biotech IPO.

IPO Details

Paytm IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Windlas Biotech IPO is ₹460.00 per share.

  Paytm IPO Windlas Biotech IPO
Face Value ₹1 per share ₹5 per share
Issue Price (Lower) ₹2,080.00 per share ₹448.00 per share
Issue Price (Upper) ₹2,150.00 per share ₹460.00 per share
Issue Price (Final) ₹2,150.00 per share ₹460.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 6 shares 30 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹8,300.00 Cr up to ₹165.00 Cr
OFS Issue Size 51,42,067 shares
OFS Issue Size (Amount) up to ₹10,000.00 Cr up to ₹236.54 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹18,300.00 Cr up to ₹401.54 Cr

IPO Timetable

Paytm IPO opens on Nov 08, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Paytm IPO and Windlas Biotech IPO is Nov 10, 2021, and Aug 06, 2021, respectively.

  Paytm IPO Windlas Biotech IPO
Anchor Bid Date
Issue Open Nov 08, 2021 Aug 04, 2021
Issue Close Nov 10, 2021 Aug 06, 2021
Basis Of Allotment (Tentative) Nov 15, 2021 Aug 11, 2021
Initiation of Refunds (Tentative) Nov 16, 2021 Aug 12, 2021
Credit of Share (Tentative) Nov 17, 2021 Aug 13, 2021
Listing date (Tentative) Nov 18, 2021 Aug 16, 2021
Anchor Lockin End date 1 Dec 15, 2021 Sep 10, 2021
Anchor Lockin End date 2 Feb 13, 2022 Nov 09, 2021

Financials

Paytm IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .

  Paytm IPO Windlas Biotech IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
30-Jun-21 30-Jun-20 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 94,590 102,777 91,513 103,031 87,668
Total Revenue 9,480 6,494 31,868 35,407 35,797
Profit After Tax (3,819) (2,844) (17,010) (29,424) (42,309)
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22
Promoter Shareholding (Pre-Issue) 78%
Promoter Shareholding (Post-Issue) 65.16%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Paytm IPO retail investors (RII) are offered 87,98,076 shares while in Windlas Biotech IPO retail investors are offered 87,98,076 shares. Qualified institutional buyers (QIB) are offered 2,63,94,231 shares in Paytm IPO and 17,23,700 shares in Windlas Biotech IPO.

  Paytm IPO Windlas Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 2,63,94,231 shares 17,23,700 shares
NII 1,31,97,115 shares 13,23,766 shares
RII 87,98,076 shares 30,88,786 shares
Employee 0 shares 0 shares
Others
Total 4,83,89,422 shares 61,36,252 shares

Bids Received (Subscription)

Paytm IPO subscribed 1.89x in total, whereas Windlas Biotech IPO subscribed 22.44x.

  Paytm IPO Windlas Biotech IPO
QIB (times) 2.79x 24.40x
NII (times) 0.24x 15.73x
Big NII (times)
Small NII (times)
RII (times) 1.66x 24.22x
Employee (times)
Other (times)
Total (times) 1.89x 22.44x

Comments

Add a public comment...